![Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days]({"type":"image" , "src" : "/sda/5944/TOC-Subject-Sample-2021-Medicine-Dentistry-Nursing-Allied-Health.jpg"})
Preview
The value of intensified insulin regimens in slowing the progression of microvascular complications in patients with type I diabetes mellitus was demonstrated in the landmark Diabetes Control and Complications Trial that ended last year. In this article, Dr Hollander, who was a member of the study's multicenter research group, discusses the practical aspects of its key components and recommends methods of achieving glucose control in these patients.
Additional information
Notes on contributors
Priscilla Hollander
Priscilla Hollander, MD Dr Hollander is a member of the division of endocrinology and diabetes and is vice president for adult diabetes and special studies, International Diabetes Center. Park Nicollet Medical Center, Minneapolis. She is also a member of the Editorial Board of POSTGRADUATE MEDICINE.